Abbott Laboratories (ABT) Long-Term Deferred Tax (2009 - 2026)
Abbott Laboratories (ABT) posted Long-Term Deferred Tax of $18.3 billion for Q2 2026, little changed sequentially from $18.4 billion in Q1 2026, and up 5.86% YoY from $17.3 billion in Q2 2025.
Abbott Laboratories (ABT) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Long-Term Deferred Tax for 16 years, with the latest figure at $18.3 billion in Q2 2026.
- Quarterly Long-Term Deferred Tax rose 5.86% year-over-year to $18.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.3 billion (up 5.86% YoY) and the FY2025 annual result came in at $18.4 billion, up 11.93% from the prior year.
- Long-Term Deferred Tax was little changed at $18.3 billion in Q2 2026 per ABT's latest filing, from $18.4 billion in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $18.4 billion in Q4 2025 and troughed at $5.4 billion in Q2 2022.
- A 5-year average of $10.8 billion and a median of $7.6 billion in 2024 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2024 and 2026: Long-Term Deferred Tax soared 131.91% in 2024, then gained 5.86% in 2026.
- Over 5 years, Long-Term Deferred Tax stood at $6.0 billion in 2022, then rose by 17.64% to $7.1 billion in 2023, then jumped by 131.91% to $16.5 billion in 2024, then increased by 11.93% to $18.4 billion in 2025, then slipped by 0.55% to $18.3 billion in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $18.3 billion, $18.4 billion, and $18.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.32 Bn |
| Mar 31, 2026 | 18.36 Bn |
| Dec 31, 2025 | 18.42 Bn |
| Sep 30, 2025 | 17.32 Bn |
| Jun 30, 2025 | 17.31 Bn |
| Mar 31, 2025 | 16.84 Bn |
| Dec 31, 2024 | 16.46 Bn |
| Sep 30, 2024 | 8.01 Bn |
| Jun 30, 2024 | 7.65 Bn |
| Mar 31, 2024 | 7.49 Bn |
| Dec 31, 2023 | 7.10 Bn |
| Sep 30, 2023 | 6.53 Bn |
| Jun 30, 2023 | 6.51 Bn |
| Mar 31, 2023 | 6.43 Bn |
| Dec 31, 2022 | 6.03 Bn |
| Sep 30, 2022 | 5.37 Bn |
| Jun 30, 2022 | 5.36 Bn |
| Mar 31, 2022 | 5.50 Bn |
| Dec 31, 2021 | 5.21 Bn |
| Sep 30, 2021 | 4.05 Bn |